Aminoglycoside antibiotics (e.g., tobramycin, gentamicin, and the recently introduced netilmicin) are widely used against serious infections with Gram-negative bacilli. These antibiotics have a narrow therapeutic range and their severe dose-dependent side-effects, notably ototoxicity and nephrotoxicity, are well documented (e.g., 1-3). Furthermore, because concentrations in serum after parenteral administration are difficult to predict and subject to individual variation (4), therapy must be monitored by their determination.
Intra-and interassay variation was below 8%. Analytical recovery of each of the three drugs was 92 to 100%. Correlation with microbiological and radioimmunological assay methods was good. The assay is rapid (about 30 mm), precise, and specific, and seems suitable for use in a routine clinical laboratory.
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"h1ghpressure" liquid chromatography #{149} drug assay fluorometry #{149} monitoring therapy#{149} biological half-life of netilmicin #{149} gentamicin . tobramycin Aminoglycoside antibiotics (e.g., tobramycin, gentamicin, and the recently introduced netilmicin) are widely used against serious infections with Gram-negative bacilli. These antibiotics have a narrow therapeutic range and their severe dose-dependent side-effects, notably ototoxicity and nephrotoxicity, are well documented (e.g., 1-3). Furthermore, because concentrations in serum after parenteral administration are difficult to predict and subject to individual variation (4), therapy must be monitored by their determination.
Traditionally, microbiological assays are used for these and other antibioticsdespite a number of drawbacks such as variableprecision,a time-consuming incubation period,and limited specificity because of interference by other microbial agents (5) . Recently, chemical assays involving "high-pressure" liquid chromatography have been presented as an alternative to microbiological methods (for a review, see ref. 6). These chemical procedures are generally rapid, and the separation step involved assures a high specificity. Precision can be controlled by good chemical practice and is generally better than for microbiological assays.
Here we present a method that is well suited for the routine assay of netilmicin, tobramycin, and gentamicin in serum. It satisfies the requirements of specificity, sensitivity, and pre- cision, and correlates excellently with existing methodology. To 0.9 mL of pooled human serum is added 0.1 mL of a water solution of aminoglycoside (final drug concentration between 0.5 and 20 mg/L).
Materials and Methods

Reagents and Instrumentation
In vivo serum samples. Three healthy volunteers were given 1.5 mg of netilmicin sulfate per kilogram body weight intravenously during 2 mm and blood was drawn after various intervals up to 8 h. Serum samples were also obtained from patients being treated with gentamicin. Blood was collected from patients receiving various drugs other than aminoglycosides, to use in assessing the specificityof the assay system. RETENTION TIME (mm) 
Results
Netilmicin and tobramycin were eluted as distinct peaks with mobile phase I (Figure 1, a and b) , the retention times Analytical recovery of drug from serum (Table 1) , as determined by comparison with peak heights obtained on analysis of aqueous standard solutions, was quantitative. In addition, re-extraction with phosphate buffer or ethyl acetate of the lower phases from samples containing 20 mg/L demonstrated that no measurable amount of drug remained in them.
Conditions for protein precipitation and drug recovery were optimal in samples diluted five-to 10-fold in alkaline phosphate buffer (see under Procedure). Tobrainycin recovery was quantitative for serum samples diluted 10-fold, whereas lower dilutions gave incomplete recovery (Figure 3 ). In contrast, netilmicin and gentamicin were recovered quantitatively regardless of the degree of dilution.
The fluorescence intensity of the drug derivatives left at room temperature or at 4 #{176}C decreased continuously at a rate of about 5% per hour. However, no loss of fluorescence was observed after 8 h in the case of storage at -20 #{176}C. In one experiment, gentamicin extracts were analyzed four days after preparation and found to be completely preserved. Serum samples could be stored for at least six months at -20 #{176}C without signs of aminoglycoside deterioration.
The sensitivity of the method as described here allowed 
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BUFFER VOLUME (ml) Precision of the methodology is demonstrated for netilmicin in Table 2 . Even at low concentrations, both intra-and interassay variation were less than 8%. The assays for tobramycin and gentamicin showed similar precision.
The specificity of the assay seems satisfactory. When analyzing samples containing various commonly used drugs (including other antibiotics, Table 3 ), we observed no peaks. Samples of serum from three healthy volunteers after intravenous injection of netilmicin were also analyzed with microbiological and radioimmunological assays. Figure 4 illustrates that results by the chemical assay correlate well with those by the comparison methods (correlation coefficients 0.99, 0.98; slopes of regression lines near 1.0). Samples from patients being treated with gentamicin were also analyzed by a microbiological technique, and a good correlation was found (n = 17, slope of regression line 0.94, intercept 0.04, correlation coefficient 0.97).
The disappearance of netilmicin from the circulation after an intravenous injection was monitored in three healthy vol- 
Discussion
The various procedures described for chemical-chromatographic assay of ammnoglycoside antibiotics in serum involve sample preparation and successive separation by liquid chromatography. The first step is the more time-consuming and therefore several samples will usually be processed concurrently.
We believe that it is advantageous to be able to use identical extraction procedures for all three aminoglycosides; the present technique satisfies this requirement.
However, we found it impossible to use identical chromatographic conditions for all three drugs. Separation of tobramycin and netilmicin with mobile phase II gave inconveniently long retention times and flat, broad peaks. Moreover, separation of gentamicin with mobile phase I proved impractical because one of the derivatized components (C1) was not retained on the column but eluted in the void volume. From the practical point of view, the separate chromato- graphic systems represent a minor problem. When a gentamicin sample is to be injected, one merely alters the mobile phase and allows the column to equilibrate (about 10 mm). When analyzing single samples, the column is equilibrated during the initial processing step. The extraction system used in the present method represents a modification of the procedure described by Peng et al. (9, 10) . The use of o-phthalaldehyde as fluorophor instead of dansyl chloride simplifies the procedure, because the ophthalaldehyde reaction proceeds rapidly at ambient temperature, thereby eliminating the need for a hot-water bath.
Dilution
with buffer before the final extraction step (9) can also be omitted.
In contrast to the gentamicin assay described by Peng et al. (9), in our assay each of the three major components of gentamicin can be quantitated, allowing detailed pharmacokinetic studies. Our previous approach to gentamicin quantitation, involving separation of the drug on disposable silicic acid columns (7), was found to give incomplete recovery of netilmicin and tobramycin. The reason for this is unknown, but the phenomenon may represent fluorometric quenching (Ii), because there is no evidence of loss of drug during the preparation and derivatizing procedure.
Because of the inhomogeneity of netilmicin in aqueous media, reflected in the chromatogram as a very broad peak, the mobile phase had to be buffered, to sharpen the peak and thereby improve sensitivity and minimize risk of interference. Addition of triethylamine to the eluentalsoimproved the chromatographic pattern by eliminating peaks in the blank samples.
Analytical recovery of gentamicin and netilmicin seems insensitive to the degree of dilution in the first extraction step. In contrast, we found it necessary to keep the sample volume for tobramycin at 0.1 mL, because attempts to increase the serum volume consistently gave incompleteyield(Figure3).
There is no evidence for binding of tobramycin by serum proteins (12), so the losses probably represent co-precipitation of drug in the initial precipitation step. Modifications of the procedure for protein precipitation (such as adjustment of the ionic strength of the phosphate buffer) failed to improve recovery.
In conclusion, we believe that this rapid, specific, and simple assayoffers an attractive alternative to existing methods such as microbiological and radioimmunological assays.
